Abstract
Activation of P2X3and P2X2/3receptors (P2X3R/P2X2/3R), ionotropic ATP receptor subtypes, in primary sensory neurons is involved in neuropathic pain, a debilitating chronic pain that occurs after peripheral nerve injury. However, the underlying mechanisms remain unknown. We investigated the role of cytosolic phospholipase A2(cPLA2) as a downstream molecule that mediates the P2X3R/P2X2/3R‐dependent neuropathic pain. We found that applying ATP to cultured dorsal root ganglion (DRG) neurons increased the level of Ser505‐phosphorylated cPLA2and caused translocation of Ser505‐phosphorylated cPLA2to the plasma membrane. The ATP‐induced cPLA2activation was inhibited by a selective antagonist of P2X3R/P2X2/3R and by a selective inhibitor of cPLA2. In the DRGin vivo, the number of cPLA2‐activated neurons was strikingly increased after peripheral nerve injury but not after peripheral inflammation produced by complete Freund’s adjuvant. Pharmacological blockade of P2X3R/P2X2/3R reversed the nerve injury‐induced cPLA2activation in DRG neurons. Moreover, administering the cPLA2inhibitor near the DRG suppressed nerve injury‐induced tactile allodynia, a hallmark of neuropathic pain. Our results suggest that P2X3R/P2X2/3R‐dependent cPLA2activity in primary sensory neurons is a key event in neuropathic pain and that cPLA2might be a potential target for treating neuropathic pain.

This publication has 59 references indexed in Scilit: